Nicotinamide phosphoribosyltransferase inhibitor is a novel therapeutic candidate in murine models of inflammatory lung injury.
Moreno-Vinasco L, Quijada H, Sammani S, Siegler J, Letsiou E, Deaton R, Saadat L, Zaidi RS, Messana J, Gann PH, Machado RF, Ma W, Camp SM, Wang T, Garcia JG.
Moreno-Vinasco L, et al.
Am J Respir Cell Mol Biol. 2014 Aug;51(2):223-8. doi: 10.1165/rcmb.2012-0519OC.
Am J Respir Cell Mol Biol. 2014.
PMID: 24588101
Free PMC article.